Skip to Content

  • Search

View Additional Section Content

A Phase III, Multicenter, Randomized, Double-Blind, Active-Comparator Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin Compared with the Addition of Dapagliflozin in Subjects with Type 2 Diabetes Mellitus and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea

Clinical Trial Categories

  • Diabetes
Contact
Renee Backer, CCRC at 215-361-7164
or research@greenandseidner.com

Location

  • Green and Seidner Family Practice Associates, PC
    826 North Broad Street
    Lansdale, PA 19446
    Office: 215-855-1054
    Fax: 215-855-3786

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details